Download PDF
Thromb Haemost 1984; 51(01): 016-021
DOI: 10.1055/s-0038-1660999
Original Article
Schattauer GmbH Stuttgart

Preparation and Characterization of NH2-Terminal Fibrinogen Bβ Fragments from N-DSK of Human Fibrinogen

S Birken
The Department of Medicine, College of Physicians and Surgeons of Columbia University, New York, N.Y., U.S.A.
,
G Agosto
The Department of Medicine, College of Physicians and Surgeons of Columbia University, New York, N.Y., U.S.A.
,
B Lahiri
The Department of Medicine, College of Physicians and Surgeons of Columbia University, New York, N.Y., U.S.A.
,
R Canfield
The Department of Medicine, College of Physicians and Surgeons of Columbia University, New York, N.Y., U.S.A.
› Author Affiliations
Further Information

Publication History

Received 13 July 1983

Accepted 03 November 1983

Publication Date:
19 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

In order to investigate the early release of NH2-terminal plasmic fragments from the Bβ chain of fibrinogen, substantial quantities of Bβ 1-42 and Bβ 1-21 are required as immunogens, as radioimmunoassay standards and for infusion into human volunteers to determine the half-lives of these peptides. Towards this end methods that employ selective proteolytic cleavage of these fragments from fibrinogen have been developed. Both the N-DSK fragment, produced by CNBr cleavage of fibrinogen, and Bβ 1-118 were employed as substrates for plasmin with the finding of higher yields from N-DSK. Bβ 1-42 and Bβ 1-21 were purified by gel filtration and ion-exchange chromatography on SP-Sephadex using volatile buffers. When the purified preparation of Bβ 1-42 was chromatographed on reverse-phase high performance liquid chromatography, two peaks of identical amino acid composition were separated, presumably due either to pyroglutamate or to amide differences.

Key Words

Fibrin degradation products - Plasmin - Fibrinogen
 

  • References

  • 1 Nossel HL, Wasser J, Kaplan KS, LaGamma KS, Yudelman I, Canfield RE. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline. J Clin Invest 1979; 64: 1371-1378
    CrossrefPubMedGoogle Scholar
  • 2 Nossel HL. Relative proteolysis of fibrinogen Bβ chain by thrombin and plasmin as a determinant of thrombosis. Nature 1981; 291: 165-167
    CrossrefPubMedGoogle Scholar
  • 3 Deutsch DG, Mertz ET. Plasminogen: Purification from human plasma by affinity chromatography. Science 1975; 170: 1095-1096
    PubMedGoogle Scholar
  • 4 Robbins KC, Summaria L. Human plasminogen and plasmin. In: Methods of Enzymology. Perlmann GE, Lorand L. (eds) Academic Press; New York, London: 1970. 19 184-199
    Google Scholar
  • 5 McClintock DK, Englert ME, Dziobkowski C, Snedeker EH, Bell PH. Two distinct pathways of the streptokinase-mediated activation of highly purified human plasminogen. Biochemistry 1974; 13: 5334-5344
    CrossrefPubMedGoogle Scholar
  • 6 Blomback B, Hessel B, Iwanaga S, Reuterby J, Blomback M. Primary structure of human fibrinogen and fibrin. I. Cleavage of fibrinogen with cyanogen bromide. Isolation and characterization of NH2- terminal fragments of the α (“A”) chain J Biol Chem 1976; 247: 1496-1512
    PubMedGoogle Scholar
  • 7 Collen D, Kudryk B, Hessel B, Blomback B. Primary structure of human fibrinogen and fibrin. J Biol Chem 1975; 250: 5808-5817
    PubMedGoogle Scholar
  • 8 Bilezikian SB, Nossel HL, Butler Jr VP, Canfield RE. Radioimmunoassay of human fibrinopeptide B and kinetics of fibrinopeptide cleavage by different enzymes. J Clin Invest 1975; 56: 438-445
    CrossrefPubMedGoogle Scholar
  • 9 Canfield RE, Dean J, Nossel HL, Butler Jr VP, Wilner GD. Reactivity of fibrinogen and fibrinopeptide A containing fibrinogen fragments with antisera to fibrinopeptide A. Biochemistry 1976; 15: 1203-1207
    CrossrefPubMedGoogle Scholar
  • 10 Margolies MN, Brauer A. Protein microsequencing using high- pressure liquid chromatography of Phenthiohydantoin amino acids. J Chromatogr 1978; 148: 429-439
    CrossrefPubMedGoogle Scholar
  • 11 Mendez E, Lai CY. Regeneration of amino acids from thiazolinones formed in the Edman degradation. Anal Biochem 1975; 68: 47-53
    CrossrefPubMedGoogle Scholar
  • 12 Fullmer CS, Wasserman RH. Analytical peptide mapping by high performance liquid chromatography. J Biol Chem 1979; 254: 7208-7212
    PubMedGoogle Scholar
  • 13 Eckhardt T, Nossel HL, Hurlet-Jensen A, LaGamma KS, Owen J, Auerbach M. Measurement of desarginine fibrinopeptide B in human blood. J Clin Invest 1981; 67: 809-816
    CrossrefPubMedGoogle Scholar
  • 14 Iwanaga S, Wallen P, Grondahl NJ, Henschen A, Blomback B. On the primary structure of human fibrinogen isolation and characterization of N-terminal fragments from plasmic digests. Eur J Biochem 1969; 8: 189-199
    CrossrefPubMedGoogle Scholar
  • 15 Kowalska-Loth B, Gardlund B, Egberg N, Blomback B. Plasmic degradation products of human fibrinogen. II. Chemical and immunological relation between fragment E and N-DSK. Thromb Res 1973; 2: 423-450
    CrossrefPubMedGoogle Scholar
  • 16 Lahiri BL, Shainoff JR. Fate of fibrinopeptides in the reaction between human plasmin and fibrinogen. Biochim Biophys Acta 1973; 303: 161-170
    CrossrefPubMedGoogle Scholar
  • 17 Mosesson MW, Finlayson JS, Umfleet RA, Galanakis D. Human fibrinogen heterogeneities. J Biol Chem 1972; 247: 5210-5219
    PubMedGoogle Scholar
  • 18 Takagi T, Doolittle RF. Amino acid sequence studies on plasmin- derived fragments of human fibrinogen: Amino-terminal sequences of intermediate and terminal fragments. Biochemistry 1975; 14: 940-946
    CrossrefPubMedGoogle Scholar
  • 19 Koehn JA, Hurlet-Jensen A, Nossel HL, Canfield RE. Sequence of plasmin proteolysis at the NH2-terminus of the Bβ-chain of human fibrinogen. Anal Biochem 1984; 133: 502-510
    PubMedGoogle Scholar
  • 20 Henschen A, Lottspeich F, Kehl M, Southan C. Covalent structure of fibrinogen. Ann N Y Acad Sci 1983; 408: 28-43
    CrossrefPubMedGoogle Scholar